dc.creatorMallol, Javier
dc.creatorBarrueto, Luis
dc.creatorGirardi, Guido
dc.creatorToro, Olivia
dc.date.accessioned2019-01-29T14:47:53Z
dc.date.available2019-01-29T14:47:53Z
dc.date.created2019-01-29T14:47:53Z
dc.date.issued1987
dc.identifierPediatric Pulmonology, Volumen 3, Issue 5, 2018, Pages 352-356
dc.identifier10990496
dc.identifier87556863
dc.identifier10.1002/ppul.1950030511
dc.identifierhttp://repositorio.uchile.cl/handle/2250/160647
dc.description.abstractTwenty‐eight infants admitted to Exequiel Gonzalez Cortes Children's Hospital because of acute wheezing (AW) were randomly assigned to three study groups. Fenoterol (FNT), ipratropium bromide (IB), and placebo were administered respectively to children in the different groups by means of metered dose inhalers (MDI) with spacers, using doses of 3 puffs every hour, for 4 hours. The degree of bronchial obstruction was assessed clinically and scored with the single‐blind method every hour prior to each treatment. The criterion of a bronchodilator effect was a significant decrease in the degree of bronchial obstruction at subsequent scorings. The scores of the three groups were compared using the Student's t test for matched samples. The same test was also applied to the independent samples for determining the superiority of one treatment, FNT or IB, over the other. The results indicated a significant decrease in the scores of the groups receiving FNT and IB (P < 0.05); this did not occur i
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourcePediatric Pulmonology
dc.subjectcomparative effectivity by clinical score
dc.subjectinfants, average age 10 mos
dc.subjectMetered dose inhaler with spacer
dc.subjectsingle‐blind, randomized, placebo‐controlled study
dc.titleBronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: Use of MDI with a spacer device
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución